Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: J Immunol. 2019 Apr 22;202(11):3256–3266. doi: 10.4049/jimmunol.1801384

Table I.

List of CD82 SNPs associated with cytokine changes and candidemia susceptibility

SNPs eQTL
p-value
Cytokine Affected Affected Sample cQTL
p-value
Candidemia Susceptibility
p-value
Risk Allele Frequency Candidemia Susceptibility Odds Ratio
rs12282890 6.22E-06 IL-1β Candida blastospores, (HK), WB, 48 hr 0.0122 NS n/a n/a
rs12282890 6.22E-06 IL-17 C. albicans blastospores, PBMC, 7 days 0.0471 NS n/a n/a
rs1429553 1.11E-03 IL-6 C. albicans hyphae, PBMC, 24 hr 0.0018 NS n/a n/a
rs7932712 0.0014 none n/a NS 0.0215 C, 0.71 1.49

List of CD82 SNPs in the 500 FG cohort for Candida-induced cytokines and candidemia susceptibility in whole blood (WB) or peripheral blood mononuclear cell (PBMC) samples. Two polymorphisms were associated with changes to IL-1β, IL-17, and IL-6 cytokines. The SNP rs7932712 was associated with an elevated susceptibility to develop candidemia. eQTL, SNPs correlated with expression level of CD82; cQTL, SNPs correlated with cytokine levels; NS, SNPs were tested but are not associated with the phenotype.